Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.45 USD | -0.45% | -13.93% | -32.78% |
Apr. 15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
Mar. 22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.78% | 110M | |
-2.89% | 187B | |
-2.43% | 108B | |
-4.10% | 67.71B | |
+11.10% | 53.07B | |
+15.86% | 47.36B | |
+3.91% | 39.73B | |
+9.55% | 28.56B | |
+1.85% | 26.55B | |
+14.24% | 25.13B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- Earnings Flash (TELA) TELA BIO Posts Q2 Revenue $10.4M, vs. Street Est of $10.1M